Lemtrada Stroke

Lemtrada, a drug prescribed to patients suffering from relapsing forms of multiple sclerosis, has been linked to serious side effects including stroke and arterial dissection. When considered in tandem with existing Lemtrada problems, some drug safety experts wonder whether Lemtrada dangers outweigh the drug's benefits. Attorneys handling Lemtrada stroke lawsuits believe persons and the family members of persons who have suffered from Lemtrada problems may be eligible for significant compensation. This page provides comprehensive information on Lemtrada stroke and artery tears compiled by attorneys handling Lemtrada stroke lawsuits for clients nationwide.

How Lemtrada Works

Lemtrada (alemtuzumab) is approved for use in patients suffering from a form of MS that causes attacks or relapses, severe incidents during which MS symptoms worsen periodically. Lemtrada is known as a recombinant humanized monoclonal antibody which decreases inflammation by first depleting the quantity of T and B cells, which has the effect of stimulating lymphocytes. This therapy is thought to alter immune system patterns in a way that may reduce MS disease activity into the future.

Lemtrada was first approved in 2014 for the treatment of relapsing MS; it is one of several drugs approved for this use. Due to the number of severe Lemtrada side effects and the inconvenient intravenous method of dispensation, Lemtrada's release was accompanied by a comprehensive risk evaluation and mitigation strategy (REMS), mandated by the FDA. Initial Lemtrada problems were identified as a risk for certain autoimmune conditions and some forms of cancer. The Lemtrada stroke risk was added to the product's Black Box warning in 2018. Due to the number of significant Lemtrada side effects, this drug is recommended only for patients for whom alternative therapies have proven ineffective. Lemtrada is also known by the brand name Campath, which is approved to treat B-cell chronic lymphocytic leukemia.

Lemtrada Problems

Lemtrada now carries a Black Box Warning, the most severe form of FDA warning, for multiple side effects including Lemtrada stroke, arterial dissection, autoimmune conditions, anaphylaxis and other serious infusion reactions, and malignancies such as thyroid cancer, melanoma, and lympho-proliferative disorders. Lemtrada stroke and arterial tears are the newest severe risks posed by this drug. Both arterial dissection and stroke from Lemtrada typically occur in the first 1-3 days after the initial intravenous treatment.

Lemtrada Arterial Dissection

Arterial dissection is a life-threatening condition that occurs when tears form in the lining of arteries in the head and neck. Arterial dissection tears usually occur abruptly; as they grow, a small pouch known as a "false lumen" forms. Blood gathering inside this false lumen can block blood flow and cause a stroke.

Stroke occurs when blood flow to an area of the brain is cut off, or when bleeding on the brain occurs. Brain cells that are deprived of oxygen begin to die in a matter of minutes. Lemtrada stroke can lead to permanent disability and death.

Symptoms of arterial dissection or stroke from Lemtrada are typically vague in the beginning, making early detection unlikely. Early Lemtrada stroke signs include headache or neck pain. Advanced symptoms of Lemtrada stroke caused by arterial dissection include

sudden numbness or weakness in the face, arms, or legs, particularly in just one side of the body
sudden confusion, trouble speaking, and difficulty understanding speech
sudden trouble seeing, in one or both eyes
sudden trouble walking, dizziness, loss of coordination or balance
sudden severe headache or neck pain

Critics say inadequate safety testing is to blame for Sanofi's failure to detect the risk for Lemtrada stroke in premarket testing. It is only as a result of severe incidents suffered by patients taking Lemtrada that the public has learned of this risk. If you or a loved one has experienced Lemtrada stroke, you may be eligible for real compensation for the pain, suffering and loss resulting from this dangerous drug.

Let Our Lemtrada Stroke Lawyers Help You

Our attorneys specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.

Lemtrada Stroke Lawsuits

Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.